CMS Finalizes Policy to Facilitate Faster Biosimilar Uptake but Follow-on Policies and Actions Still Needed
top of page
NEWS
The Centers for Medicare & Medicaid Services (CMS) recently released a final rule allowing Medicare Advantage and Part D health plans to...
- Apr 3
Commonsense Policies Needed to Lower Healthcare Costs and Improve Patient Access While Protecting Drug Development Pipeline
Today, President Biden highlighted the administration’s current and future efforts to lower healthcare costs. The good news is recent...
- Mar 12
Vendors Power America's Biopharmaceutical Industry
We Work For Health recently released new employment, vendor and supplier expenditure data that showcases the vital contributions of these...
- Mar 7
President Biden’s State of the Union Call for IRA Expansion Hurts Patients, Workers, and U.S. Leadership
During his State of the Union address Thursday night, President Biden called for Congress to expand the Inflation Reduction Act to...
- 4 days ago
CMS Finalizes Policy to Facilitate Faster Biosimilar Uptake but Follow-on Policies and Actions Still Needed
The Centers for Medicare & Medicaid Services (CMS) recently released a final rule allowing Medicare Advantage and Part D health plans to...
- Apr 26
Statement by We Work For Health Executive Director Dan Leonard on World IP Day
FOR IMMEDIATE RELEASE April 26, 2024 WASHINGTON, D.C. – We Work For Health Executive Director Dan Leonard issued the following statement...
- Apr 3
Commonsense Policies Needed to Lower Healthcare Costs and Improve Patient Access While Protecting Drug Development Pipeline
Today, President Biden highlighted the administration’s current and future efforts to lower healthcare costs. The good news is recent...
- Mar 28
Paths to Progress: Understanding Policy’s Broad Impact on US Leadership in Biopharma
We Work For Health recently convened a conversation to explore the impact policy decisions have on the biopharmaceutical industry and...
bottom of page